Apolipoprotein A-I dysregulation is associated with blood–brain barrier dysfunction, oxidative stress and inflammation, which are elements of Parkinson’s disease and Alzheimer’s disease (AD) [5,6]. This evidence concerns the gene APOA1 and Alzheimer disease.